Regulation .04 Pharmacist Responsibilities.
Regulation .04 Pharmacist Responsibilities.LinkCopy Citation
A.
A pharmacist in an infusion pharmacy shall adhere to the policies and procedures set forth in Regulation .06 of this chapter.
B.
A pharmacist shall:
(1)
Provide infusion therapy services in accordance with:
(a)
Orders issued by a licensed authorized prescriber of record; and
(b)
Where applicable, protocols issued by a licensed authorized prescriber of record.
(2)
Perform and document initial and ongoing assessments of the appropriateness of infusion therapy using the following information:
(a)
Patient demographics including:
(i)
Name;
(ii)
Address;
(iii)
Telephone number;
(iv)
Gender; and
(v)
Date of birth;
(b)
Emergency contact information;
(c)
Diagnoses, including:
(i)
Diagnosis being treated; and
(ii)
Concurrent conditions, including pregnancy and lactation status if applicable;
(d)
Medical history;
(e)
Allergies;
(f)
If applicable, height;
(g)
Weight;
(h)
Parenteral medication orders, including length of therapy;
(i)
Parenteral infusion access device:
(i)
Location;
(ii)
Type; and
(iii)
If available, date of placement;
(j)
Ongoing medication profile review and reconciliation at end of therapy;
(k)
First dose status;
(l)
Caregiver information including, but not limited to:
(i)
Name;
(ii)
Address;
(iii)
Phone number; and
(iv)
Relationship to patient;
(m)
If applicable, contact information for other agencies or individuals involved in the patient’s home care;
(n)
Documented applicable medical and social factors and functional limitations which may affect infusion therapy including but not limited to:
(i)
Language;
(ii)
Sight;
(iii)
Hearing;
(iv)
History of IV drug abuse;
(v)
History of drug or alcohol abuse; or
(vi)
Other physical or mental limitations; and
(o)
If applicable to therapy, baseline labs;
(3)
Create a patient care plan specific to the patient’s:
(a)
Diagnosis;
(b)
Prescribed therapy; and
(c)
Concurrent conditions;
(4)
When compounding sterile preparations, comply with COMAR 10.34.19;
(5)
If sterile compounding is outsourced, comply with COMAR 10.34.04;
(6)
As applicable, retrieve and assess lab values and other monitoring parameters;
(7)
Document in the patient chart:
(a)
New prescription orders;
(b)
Changes in prescription orders;
(c)
Information obtained from the patient or caregiver; and
(d)
Other necessary information obtained from the:
(i)
Patient;
(ii)
Caregiver;
(iii)
Infusion nurse;
(iv)
Licensed authorized prescriber of record; or
(v)
Other sources relevant to patient care;
(8)
Verify prescription label accuracy;
(9)
Communicate as appropriate, throughout the patient’s therapy with the:
(a)
Licensed authorized prescriber of record or agent of the licensed authorized prescriber of record;
(b)
Patient’s infusion nurse;
(c)
Patient; and
(d)
Caregiver; and
(10)
Review therapy-specific considerations such as pain and nutrition status.